Skip to main content
logo
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (HKG:6990)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
538.00
+5.00 (0.94%)
Aug 21, 2026, 4:08 PM HKT

HKG:6990 Revenue

Sichuan Kelun-Biotech Biopharmaceutical had revenue of 978.34M CNY in the half year ending June 30, 2026, a decrease of -29.25%. This brings the company's revenue in the last twelve months to 2.09B, up 38.99% year-over-year. In the year 2025, Sichuan Kelun-Biotech Biopharmaceutical had annual revenue of 2.06B with 6.46% growth.

Revenue (ttm)
2.09B CNY
Revenue Growth
+38.99%
P/S Ratio
53.40
Revenue / Employee
906.88K CNY
Employees
2,300
Market Cap
128.59B HKD

Revenue Chart

Chart
* This company reports financials in CNY.

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 20252.06B124.88M6.46%
Dec 31, 20241.93B392.55M25.48%
Dec 31, 20231.54B736.56M91.62%
Dec 31, 2022803.93M771.61M2,387.26%
Dec 31, 202132.32M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Related Stocks

Company NameRevenue
BeOne Medicines AG48.06B
Sino Biopharmaceutical38.91B
WuXi Biologics24.25B
3SBio19.69B
Innovent Biologics14.51B
Shanghai Henlius Biotech7.42B
Genscript Biotech6.63B
RemeGen3.84B
Revenue Rankings

Sichuan Kelun-Biotech Biopharmaceutical News

More News